Stage II HR-Positive Invasive Ductal Carcinoma: Allison's Patient Story

Patient Info: Allison Tierney, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive; CHEK2 mutation; BRCA1/2 negative

As of March 2024, Allison had completed Taxol and Herceptin treatment, was on tamoxifen planned for 10 years, and had moved to 6-month oncology follow-up. No metastatic disease or recurrence was reported.

YouTube — The Patient StoryRead more →

Stage II Colorectal Cancer: Savannah's Survivor Story

Patient Info: Savannah Kaspar, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome genetic testing negative

As of March 2024, Savannah had completed partial colectomy and 4 rounds of adjuvant chemotherapy for Stage II sigmoid colon cancer and had entered surveillance with bloodwork every 3 months.

MD AndersonRead more →

Stage IV Ovarian Cancer: Susan's Patient Story

Patient Info: Susan Dunwoody, female | Stage IV

Susan lived for 7 years after her Stage IV ovarian cancer diagnosis and later died from the disease.

MD AndersonRead more →

Stage III Invasive Lobular Carcinoma: Harvey's Patient Story

Patient Info: Harvey, Male, 50s | Stage III

Biomarkers: Genetic testing negative

Harvey was in active treatment for male Stage IIIC grade 3 ILC after right mastectomy and initiation of AC-T chemotherapy, with radiation and endocrine/targeted therapy planned as of March 2024.

Lobular Breast Cancer AllianceRead more →

Stage II Triple-Negative Breast Cancer: Chance's Survivor Story

Patient Info: Chance Osborne, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of March 2024, Chance Osborne was a young Stage II TNBC survivor with a BRCA1 mutation, sharing her experience with chemotherapy, double mastectomy recovery, and advocacy.

Malignant Phyllodes Tumor Recurs Early Along the Biopsy Tract in a Young Woman

Patient Info: Anonymized, female

Biomarkers: No pathogenic germline mutations identified; MLH1 variant of uncertain significance

Clinical examination, breast MRI, and chest CT showed no evidence of disease at about 3 months after the recurrence surgery and before the 6-month follow-up.

PubMed CentralRead more →

Ovarian Clear Cell Cancer Surgery Followed by a Serious Bowel Complication

Patient Info: Anonymized, Female

She recovered from the bowel perforation and reactive subdiaphragmatic cyst, stopped infection medication after negative cultures, and was discharged 78 days after the initial surgery while additional anticancer treatment remained planned.

PubMed CentralRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Dorian's Survivor Story

Patient Info: Dorian de Salvo, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of March 2024, Dorian had a complete response to TCHP chemotherapy, clear surgical margins, and no lymph-node involvement after surgery, with radiation completed and additional care still expected for several months.

The Patient StoryRead more →

Stage II lung adenocarcinoma with severe atezolizumab-related myocarditis after surgery

Patient Info: Anonymized, female, 40s | Stage II

Biomarkers: PD-L1 TPS 50%

More than 1 year after atezolizumab was discontinued, there was no recurrence of the lung cancer.

PubMed CentralRead more →

Stage IV ALK Lung Adenocarcinoma: Keegan's Survivor Story

Patient Info: Keegan Murphy, Male, 40s | Stage IV

Biomarkers: ALK fusion mutation

Metastatic Site: Lungs; lymph nodes; ribs/bone; abdomen

As of March 2024, Keegan had gone from Stage IV ALK-positive lung adenocarcinoma with tumors in the lungs, lymph nodes, ribs, and abdomen to no evidence of disease after alectinib and surgery.

MD AndersonRead more →

How I KNEW I Had COLON CANCER

Patient Info: Courtney, Female | Stage III

As of March 2024, Courtney was nearly 3 years in remission after surgery and adjuvant chemotherapy for Stage IIIA colorectal cancer, with follow-up every 6 months.

The Patient StoryRead more →

Recurrent Lobular Breast Cancer Appears in the Skin Alongside Pyoderma Gangrenosum

Patient Info: Anonymized, female, 70+

Recurrent cutaneous lobular carcinoma was confirmed on the anterior chest wall, and she died soon after the dermatology evaluation before additional cancer treatment began.

PubMed CentralRead more →

Stage IIIB to metastatic rectal cancer: setback and treatment journey

Patient Info: Justine, Female, Under 40 | Stage IV

Metastatic Site: Liver; lung

As of March 2024, Justine was living with metastatic rectal cancer involving liver and lung, described as treatable but not curable, after surgery, permanent ileostomy, IV chemotherapy, liver ablation, lung SBRT, and Y-90 liver radioembolization.

The Patient StoryRead more →

Liliana Bolaños

Patient Info: Anonymized, Female, 40s

Fight Colorectal CancerRead more →

Colon cancer recurrence at a surgical drain site

Patient Info: Anonymized, Male

He recovered well after abdominal-wall excision and was followed every 3–6 months, with no clinical signs of further recurrence or metastasis.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Linda's Patient Story

Patient Info: Linda Hartong, Female, 40s | Stage IV

Metastatic Site: liver

Linda was feeling well enough to continue treatment after right liver resection and 10 chemotherapy cycles, with further surgery and 2 final cycles planned.

Fight Colorectal CancerRead more →

Stage II Colorectal Cancer: Allison's Survivor Story

Patient Info: Allison, Female, Under 40 | Stage II

As of March 2024, Allison was a Stage IIC rectal/colorectal cancer survivor after chemoradiation, major open surgery with temporary ileostomy and J-pouch creation, and additional chemotherapy; no metastatic disease was reported.

The Patient StoryRead more →

Jason Randall: stage IV colorectal cancer and liver metastases

Patient Info: Jason Randall, Male, Under 40 | Stage IV

Metastatic Site: Liver; lung; tailbone/sacrum/pelvis

As of March 2024, Jason was 2.5 years off chemotherapy and 16 months with no evidence of disease after treatment for Stage IV rectosigmoid colorectal cancer.

City of HopeRead more →

Stage IV Non-Small Cell Lung Cancer: Tim's Patient Story

Patient Info: Tim Monds, Male, 50s | Stage IV

Biomarkers: High PD-L1 expression

Metastatic Site: Other lung lobes / lung nodules

As of March 2024, Tim Monds was identified as a Stage IV lung cancer survivor involved in discussion of the PaCES early palliative-care project and broader lung cancer advocacy.

Left Breast Cancer in a BRCA2 Carrier Treated With Mastectomy, Chemotherapy, and an Arm Port

Patient Info: Anonymized, female, Under 40

Biomarkers: Hormone receptor-positive; HER2-negative; pathogenic BRCA2 variant

At 17 months after surgery, she was free from disease and reported good quality of life and satisfaction with reconstruction and the arm port.

PubMed CentralRead more →

Occult Right Breast Cancer Found During BRCA2 Risk-Reducing Mastectomy

Patient Info: Anonymized, female, Under 40

Biomarkers: Hormone receptor-positive; HER2-negative; pathogenic BRCA2 variant

At the overall 17-month follow-up after bilateral surgery, she was free from disease.

PubMed CentralRead more →

Triple-Negative Metaplastic Breast Cancer Treated With Chemotherapy, Oncoplastic Surgery, and Radiation

Patient Info: Anonymized, female, 40s

Biomarkers: Triple-negative

Follow-up imaging and clinical examinations showed no residual or recurrent disease for 2 years after treatment.

PubMed CentralRead more →

BRCA1-Mutated Ovarian Cancer Responding to Niraparib After Olaparib Progression

Patient Info: Anonymized, Female, 60s

Biomarkers: Germline BRCA1 pathogenic variant c.188T>A; CA-125 4

Two months after starting niraparib, imaging showed a partial response and CA-125 normalized. At 15 months, she had achieved a complete response and remained progression-free while niraparib continued.

PubMed CentralRead more →

Colorectal Cancer: Stephanie's Patient Story

Patient Info: Stephanie McBride, 40s

After chemotherapy, surgery, radiation, and a temporary ileostomy, Stephanie continued managing neuropathy, pain, and increased anxiety.

Fight Colorectal CancerRead more →